Dr. Zanwar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 1st St SW
Rochester, MN 55905Phone+1 507-284-2511
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 2019 - 2022
Government Medical College NagpurClass of 2010- Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine
Certifications & Licensure
MN State Medical License 2020 - 2025
American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- Efficacy of MEK inhibitors in Erdheim-Chester disease: impact of MAPK pathway pathogenic variants.Aldo A Acosta-Medina, Jithma P Abeykoon, Saurabh Zanwar, Gordon J Ruan, Karen L Rech
Leukemia. 2025-02-11 - Autologous and Allogeneic Stem-Cell Transplantation for Transformed Waldenström Macroglobulinemia.Eric Durot, Lukshe Kanagaratnam, Saurabh Zanwar, Adrienne Kaufman, Shirley D'Sa
American Journal of Hematology. 2025-02-01 - Risk-adapted treatment for multiple myeloma: assessing the current potential and a roadmap for the future.Saurabh Zanwar, Shaji Kumar
Leukemia & Lymphoma. 2024-12-22
Journal Articles
- Primary Systemic Amyloidosis in Patients with Waldenström MacroglobulinemiaAngela Dispenzieri, Eli Muchtar, Ronald Go, Saurabh Zanwar, Surbhi Sidana, Francis Buadi, Stephen M Ansell, Prashant Kapoor, David Dingli, Thomas Habermann, Shaji Kuma..., Nature
- Daratumumab-Based Therapy in Patients with Heavily-Pretreated AL AmyloidosisSaurabh Zanwar, Angela Dispenzieri, Wilson Gonsalves, David Dingli, Jithma P Abeykoon, Martha Q Lacy, Shaji Kumar, Nelson Leung, Morie A Gertz, Eli Muchtar, Francis Bu..., Nature
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
